Exact Sciences (EXAS) News Today $52.70 -1.22 (-2.26%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Exact Sciences Co. (NASDAQ:EXAS) Shares Purchased by Connor Clark & Lunn Investment Management Ltd.Connor Clark & Lunn Investment Management Ltd. raised its position in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 59.5% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 335,705 shares of the medical research company's stock after purchasing an additNovember 21 at 5:33 AM | marketbeat.comJennison Associates LLC Has $60.26 Million Stake in Exact Sciences Co. (NASDAQ:EXAS)Jennison Associates LLC reduced its stake in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 3.4% in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 884,659 shares of the medical research company's stock after selling 30,775 shares during the quartNovember 21 at 5:32 AM | marketbeat.comSwiss National Bank Increases Holdings in Exact Sciences Co. (NASDAQ:EXAS)Swiss National Bank increased its stake in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 2.4% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 547,680 shares of the medical research comNovember 21 at 4:00 AM | marketbeat.comExact Sciences (EXAS) Receives a Buy from JefferiesNovember 20 at 5:37 PM | markets.businessinsider.comEULAV Asset Management Has $20.78 Million Position in Exact Sciences Co. (NASDAQ:EXAS)EULAV Asset Management raised its position in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 7.0% during the third quarter, according to its most recent 13F filing with the SEC. The fund owned 305,000 shares of the medical research company's stock after buying an additional 20,000 shares duringNovember 20 at 8:42 AM | marketbeat.comExact Sciences Corporation (EXAS) Jefferies London Healthcare Conference (Transcript)November 19 at 4:07 PM | seekingalpha.comExact Sciences Co. (NASDAQ:EXAS) Short Interest Down 9.5% in OctoberExact Sciences Co. (NASDAQ:EXAS - Get Free Report) was the recipient of a significant decrease in short interest in October. As of October 31st, there was short interest totalling 14,060,000 shares, a decrease of 9.5% from the October 15th total of 15,540,000 shares. Based on an average daily trading volume, of 2,400,000 shares, the short-interest ratio is currently 5.9 days.November 19 at 12:45 PM | marketbeat.comExact Sciences Co. (NASDAQ:EXAS) Given Average Rating of "Moderate Buy" by AnalystsNovember 19 at 1:15 AM | americanbankingnews.comExact Sciences Co. (NASDAQ:EXAS) Receives Consensus Rating of "Moderate Buy" from AnalystsExact Sciences Co. (NASDAQ:EXAS - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the nineteen ratings firms that are covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a hold recommendation and eighteen have issuedNovember 19 at 1:14 AM | marketbeat.comChairman of The Board & CEO of Exact Sciences Picks Up 2.7% More StockNovember 16, 2024 | finance.yahoo.comExact Sciences Co. (NASDAQ:EXAS) Shares Acquired by Simplify Asset Management Inc.Simplify Asset Management Inc. raised its position in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 67.5% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 29,277 shares of the medical researchNovember 15, 2024 | marketbeat.comSumitomo Mitsui Trust Group Inc. Sells 92,841 Shares of Exact Sciences Co. (NASDAQ:EXAS)Sumitomo Mitsui Trust Group Inc. trimmed its stake in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 8.1% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,049,935 shares of the medical resNovember 15, 2024 | marketbeat.comExact Sciences Co. (NASDAQ:EXAS) CEO Buys $1,001,325.00 in StockNovember 14, 2024 | insidertrades.comExact Sciences Unveils Data Showing Promise of Multi-Cancer Early Detection at AACR Special Conference on Liquid BiopsyNovember 13, 2024 | finance.yahoo.comExact Sciences Co. (NASDAQ:EXAS) Stock Position Decreased by Baillie Gifford & Co.Baillie Gifford & Co. cut its stake in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 15.2% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,209,501 shares of the medical research company's stock after selNovember 13, 2024 | marketbeat.comLos Angeles Capital Management LLC Takes Position in Exact Sciences Co. (NASDAQ:EXAS)Los Angeles Capital Management LLC bought a new position in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 62,062 shares of theNovember 13, 2024 | marketbeat.comWCM Investment Management LLC Boosts Stake in Exact Sciences Co. (NASDAQ:EXAS)WCM Investment Management LLC grew its stake in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 1,153.2% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 187,807 shares of the medical research company's sNovember 12, 2024 | marketbeat.comExact Sciences price target lowered to $75 from $85 at Piper SandlerNovember 12, 2024 | markets.businessinsider.comExact Sciences Corporation (EXAS) Rebounded from the Previous QuarterNovember 12, 2024 | msn.comLisanti Capital Growth LLC Makes New $1.04 Million Investment in Exact Sciences Co. (NASDAQ:EXAS)Lisanti Capital Growth LLC bought a new stake in Exact Sciences Co. (NASDAQ:EXAS - Free Report) in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 15,260 shares of the medical research company's stock, valuNovember 11, 2024 | marketbeat.comPiper Sandler Cuts Exact Sciences (NASDAQ:EXAS) Price Target to $75.00Piper Sandler lowered their price objective on Exact Sciences from $85.00 to $75.00 and set an "overweight" rating for the company in a research note on Monday.November 11, 2024 | marketbeat.comExact Sciences: Cancer Detection Stalwart's Bad Quarter Resets Its Overgrown Market Cap.November 10, 2024 | seekingalpha.comExact Sciences Co. (NASDAQ:EXAS) Shares Sold by Principal Financial Group Inc.Principal Financial Group Inc. trimmed its stake in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 19.5% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,049,256 shares of the medical research company's stock afNovember 10, 2024 | marketbeat.comExact Sciences Poised for Recovery and Long-Term Growth Amidst ChallengesNovember 8, 2024 | markets.businessinsider.comExact Sciences (EXAS) Gets a Buy from Wells FargoNovember 8, 2024 | markets.businessinsider.comQ4 EPS Estimates for Exact Sciences Decreased by AnalystExact Sciences Co. (NASDAQ:EXAS - Free Report) - Stock analysts at Leerink Partnrs reduced their Q4 2024 earnings per share estimates for Exact Sciences in a report issued on Wednesday, November 6th. Leerink Partnrs analyst P. Souda now expects that the medical research company will post earningsNovember 8, 2024 | marketbeat.comExact Sciences Co. (NASDAQ:EXAS) Stake Trimmed by ARK Investment Management LLCARK Investment Management LLC trimmed its position in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 34.0% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 227,444 shares of the medical research compNovember 8, 2024 | marketbeat.comLeerink Partnrs Predicts Weaker Earnings for Exact SciencesExact Sciences Co. (NASDAQ:EXAS - Free Report) - Equities research analysts at Leerink Partnrs dropped their Q4 2025 earnings per share estimates for Exact Sciences in a research note issued on Wednesday, November 6th. Leerink Partnrs analyst P. Souda now forecasts that the medical research compaNovember 7, 2024 | marketbeat.comExact Sciences Co. (NASDAQ:EXAS) Shares Sold by Van ECK Associates CorpVan ECK Associates Corp cut its stake in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 11.4% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 135,865 shares of the medical research company's stocNovember 7, 2024 | marketbeat.comExact Sciences price target lowered to $82 from $90 at TD CowenNovember 6, 2024 | markets.businessinsider.comExact Sciences Q3 Financial Analysis: Key Earnings and Investor InsightsNovember 6, 2024 | theglobeandmail.comExact Sciences Posts Downbeat Results, Joins Super Micro Computer, Honda Motor And Other Big Stocks Moving Lower In Wednesday's Pre-Market SessionNovember 6, 2024 | msn.comExact Sciences: Q3 Sell-Off May Be Unjustified, But Long-Term Outlook A ConcernNovember 6, 2024 | seekingalpha.comColorectal Cancer Diagnostic Focused Exact Sciences Stock Plunges On Weak Annual Guidance, Analyst Sees Compelling Long-Term Entry PointNovember 6, 2024 | benzinga.comExact Sciences: Long-Term Growth Prospects Intact Despite Short-Term ChallengesNovember 6, 2024 | markets.businessinsider.comExact Sciences (EXAS) Receives a Buy from Craig-HallumNovember 6, 2024 | markets.businessinsider.comCologuard Maker Exact Sciences Slashes Outlook as Losses MountNovember 6, 2024 | investopedia.comExact Sciences (NASDAQ:EXAS) Shares Gap Down on Disappointing EarningsExact Sciences (NASDAQ:EXAS) Shares Gap Down on Disappointing EarningsNovember 6, 2024 | marketbeat.comCraig Hallum Cuts Exact Sciences (NASDAQ:EXAS) Price Target to $65.00Craig Hallum reduced their price objective on shares of Exact Sciences from $82.00 to $65.00 and set a "buy" rating for the company in a report on Wednesday.November 6, 2024 | marketbeat.comExact Sciences (NASDAQ:EXAS) Given New $65.00 Price Target at BenchmarkBenchmark lowered their price objective on Exact Sciences from $67.00 to $65.00 and set a "buy" rating on the stock in a research note on Wednesday.November 6, 2024 | marketbeat.comExact Sciences (NASDAQ:EXAS) Price Target Lowered to $67.00 at Robert W. BairdRobert W. Baird decreased their target price on shares of Exact Sciences from $70.00 to $67.00 and set an "outperform" rating for the company in a research report on Wednesday.November 6, 2024 | marketbeat.comExact Sciences cuts FY24 revenue view to $2.73B-$2.75B, consensus $2.83BNovember 6, 2024 | markets.businessinsider.comEXACT Sciences options imply 10.2% move in share price post-earningsNovember 6, 2024 | markets.businessinsider.comExact Sciences Corp (EXAS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ...November 6, 2024 | finance.yahoo.comExact Sciences Stock Falls 29% On Weak Results, Downbeat OutlookNovember 5, 2024 | investors.comExact Sciences Corporation (EXAS) Q3 2024 Earnings Call TranscriptNovember 5, 2024 | seekingalpha.comExact Sciences Corporation 2024 Q3 - Results - Earnings Call PresentationNovember 5, 2024 | seekingalpha.comAfter-hours movers: Super Micro Computer, Exact Sciences, Trump Media & TechnologyNovember 5, 2024 | in.investing.comExact Sciences Announces Third-Quarter 2024 ResultsNovember 5, 2024 | finance.yahoo.comExact Sciences Stock Plummets After Worse-Than-Expected Q3 Results, FY24 Guidance Below EstimatesNovember 5, 2024 | benzinga.com Get Exact Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EXAS and its competitors with MarketBeat's FREE daily newsletter. Email Address [625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad)All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen. Register for the FREE Workshop Now & get $10 in Bitcoin EXAS Media Mentions By Week EXAS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EXAS News Sentiment▼1.070.46▲Average Medical News Sentiment EXAS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EXAS Articles This Week▼108▲EXAS Articles Average Week Get Exact Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EXAS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Medpace News Charles River Laboratories International News ICON Public News National Research News Alnylam Pharmaceuticals News Biogen News United Therapeutics News Incyte News Neurocrine Biosciences News BioMarin Pharmaceutical News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EXAS) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exact Sciences Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Exact Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EXAS Stock Alerts